Recombinant Bovine Growth Hormone, rbGH, Recombinant Bovine Somatotropin, rBST, human consumption
On November 5, 1993, the Food and Drug Administration (FDA) approved Recombinant Bovine Somatotropin (rBST), also JOURNAL OF FOOD LAW & POLICY called Recombinant Bovine Growth Hormone (rbGH), for commercial use to increase milk production in dairy cattle. The FDA determined that milk from cows which have been treated with rBST was safe for human consumption and that there was no significant impact on the environment from the production and use of rBST. In February 1994 the Monsanto Corporation (Monsanto) introduced POSILACO bovine somatotropin, making rBST commercially available to United States dairy farmers.
Cook-Mowery, C., Olynk, N. J., & Wolf, C. A. (2021). Farm-Level Contracting for Production Process Attributes: An Analysis of rBST in Milk Production. Journal of Food Law & Policy, 4(2). Retrieved from https://scholarworks.uark.edu/jflp/vol4/iss2/3